Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p162 has 328 genes in the original annotation. Currently, there are 259 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
3688	ITGB1	CD29 \| FNRB \| GPIIA \| MDF2 \| MSK12 \| VLA-BETA \| VLAB	integrin subunit beta 1	10p11.2
8453	CUL2	-	cullin 2	10p11.21
8325	FZD8	FZ-8 \| hFZ8	frizzled class receptor 8	10p11.21
8031	NCOA4	ARA70 \| ELE1 \| PTC3 \| RFG	nuclear receptor coactivator 4	10q11.2
5979	RET	CDHF12 \| CDHR16 \| HSCR1 \| MEN2A \| MEN2B \| MTC1 \| PTC \| RET-ELE1 \| RET51	ret proto-oncogene	10q11.2
5599	MAPK8	JNK \| JNK-46 \| JNK1 \| JNK1A2 \| JNK21B1/2 \| PRKM8 \| SAPK1 \| SAPK1c	mitogen-activated protein kinase 8	10q11.22
29119	CTNNA3	ARVD13 \| VR22	catenin alpha 3	10q22.2
5728	PTEN	10q23del \| BZS \| CWS1 \| DEC \| GLM2 \| MHAM \| MMAC1 \| PTEN1 \| TEP1	phosphatase and tensin homolog	10q23.3
4791	NFKB2	CVID10 \| H2TF1 \| LYT-10 \| LYT10 \| NF-kB2 \| p100 \| p49/p100 \| p52	nuclear factor of kappa light polypeptide gene enhancer in B-cells 2	10q24
2253	FGF8	AIGF \| FGF-8 \| HBGF-8 \| HH6 \| KAL6	fibroblast growth factor 8	10q24
1147	CHUK	IKBKA \| IKK-alpha \| IKK1 \| IKKA \| NFKBIKA \| TCF16	conserved helix-loop-helix ubiquitous kinase	10q24-q25
355	FAS	ALPS1A \| APO-1 \| APT1 \| CD95 \| FAS1 \| FASTM \| TNFRSF6	Fas cell surface death receptor	10q24.1
51684	SUFU	PRO1280 \| SUFUH \| SUFUXL	SUFU negative regulator of hedgehog signaling	10q24.32
6934	TCF7L2	TCF-4 \| TCF4	transcription factor 7 like 2	10q25.3
2263	FGFR2	BBDS \| BEK \| BFR-1 \| CD332 \| CEK3 \| CFD1 \| ECT1 \| JWS \| K-SAM \| KGFR \| TK14 \| TK25	fibroblast growth factor receptor 2	10q26
6688	SPI1	OF \| PU.1 \| SFPI1 \| SPI-1 \| SPI-A	Spi-1 proto-oncogene	11p11.2
7189	TRAF6	MGC:3310 \| RNF85	TNF receptor associated factor 6	11p12
3265	HRAS	C-BAS/HAS \| C-H-RAS \| C-HA-RAS1 \| CTLO \| H-RASIDX \| HAMSV \| HRAS1 \| RASH1 \| p21ras	Harvey rat sarcoma viral oncogene homolog	11p15.5
2950	GSTP1	DFN7 \| FAEES3 \| GST3 \| GSTP \| HEL-S-22 \| PI	glutathione S-transferase pi 1	11q13
7423	VEGFB	VEGFL \| VRF	vascular endothelial growth factor B	11q13
5970	RELA	NFKB3 \| p65	v-rel avian reticuloendotheliosis viral oncogene homolog A	11q13
595	CCND1	BCL1 \| D11S287E \| PRAD1 \| U21B31	cyclin D1	11q13
9965	FGF19	-	fibroblast growth factor 19	11q13.1
8772	FADD	GIG3 \| MORT1	Fas associated via death domain	11q13.3
2249	FGF4	HBGF-4 \| HST \| HST-1 \| HSTF1 \| K-FGF \| KFGF	fibroblast growth factor 4	11q13.3
7481	WNT11	HWNT11	wingless-type MMTV integration site family member 11	11q13.5
8322	FZD4	CD344 \| EVR1 \| FEVR \| FZD4S \| Fz-4 \| Fz4 \| FzE4 \| GPCR \| hFz4	frizzled class receptor 4	11q14.2
330	BIRC3	AIP1 \| API2 \| CIAP2 \| HAIP1 \| HIAP1 \| MALT2 \| MIHC \| RNF49 \| c-IAP2	baculoviral IAP repeat containing 3	11q22
4312	MMP1	CLG \| CLGN	matrix metallopeptidase 1	11q22.3
7704	ZBTB16	PLZF \| ZNF145	zinc finger and BTB domain containing 16	11q23.1
2113	ETS1	ETS-1 \| EWSR2 \| c-ets-1 \| p54	ETS proto-oncogene 1, transcription factor	11q23.3
867	CBL	C-CBL \| CBL2 \| FRA11B \| NSLL \| RNF55	Cbl proto-oncogene, E3 ubiquitin protein ligase	11q23.3
3845	KRAS	C-K-RAS \| CFC2 \| K-RAS2A \| K-RAS2B \| K-RAS4A \| K-RAS4B \| KI-RAS \| KRAS1 \| KRAS2 \| NS \| NS3 \| RALD \| RASK2	Kirsten rat sarcoma viral oncogene homolog	12p12.1
1027	CDKN1B	CDKN4 \| KIP1 \| MEN1B \| MEN4 \| P27KIP1	cyclin-dependent kinase inhibitor 1B	12p13.1-p12
81029	WNT5B	-	wingless-type MMTV integration site family member 5B	12p13.3
7471	WNT1	BMND16 \| INT1 \| OI15	wingless-type MMTV integration site family member 1	12q13
2735	GLI1	GLI	GLI family zinc finger 1	12q13.3
1019	CDK4	CMM3 \| PSK-J3	cyclin-dependent kinase 4	12q14
4193	MDM2	ACTFS \| HDMX \| hdm2	MDM2 proto-oncogene	12q14.3-q15
3479	IGF1	IGF-I \| IGFI \| MGF	insulin like growth factor 1	12q23.2
7184	HSP90B1	ECGP \| GP96 \| GRP94 \| HEL-S-125m \| HEL35 \| TRA1	heat shock protein 90kDa beta family member 1	12q24.2-q24.3
11211	FZD10	CD350 \| FZ-10 \| Fz10 \| FzE7 \| hFz10	frizzled class receptor 10	12q24.33
675	BRCA2	BRCC2 \| BROVCA2 \| FACD \| FAD \| FAD1 \| FANCD \| FANCD1 \| GLM3 \| PNCA2 \| XRCC11	breast cancer 2	13q12.3
2308	FOXO1	FKH1 \| FKHR \| FOXO1A	forkhead box O1	13q14.1
5925	RB1	OSRC \| PPP1R130 \| RB \| p105-Rb \| pRb \| pp110	retinoblastoma 1	13q14.2
1282	COL4A1	BSVD \| RATOR	collagen type IV alpha 1	13q34
1284	COL4A2	ICH \| POREN2	collagen type IV alpha 2	13q34
2259	FGF14	FGF-14 \| FHF-4 \| FHF4 \| SCA27	fibroblast growth factor 14	13q34
4792	NFKBIA	IKBA \| MAD-3 \| NFKBI	NFKB inhibitor alpha	14q13
112399	EGLN3	HIFP4H3 \| HIFPH3 \| PHD3	egl-9 family hypoxia-inducible factor 3	14q13.1
6655	SOS2	NS9	SOS Ras/Rho guanine nucleotide exchange factor 2	14q21
652	BMP4	BMP2B \| BMP2B1 \| MCOPS6 \| OFC11 \| ZYME	bone morphogenetic protein 4	14q22-q23
4149	MAX	bHLHd4	MYC associated factor X	14q23
3091	HIF1A	HIF-1-alpha \| HIF-1A \| HIF-1alpha \| HIF1 \| HIF1-ALPHA \| MOP1 \| PASD8 \| bHLHe78	hypoxia inducible factor 1 alpha subunit	14q23.2
7043	TGFB3	ARVD \| ARVD1 \| LDS5 \| RNHF \| TGF-beta3	transforming growth factor beta 3	14q24
5228	PGF	D12S1900 \| PGFL \| PLGF \| PlGF-2 \| SHGC-10760	placental growth factor	14q24.3
2353	FOS	AP-1 \| C-FOS \| p55	FBJ murine osteosarcoma viral oncogene homolog	14q24.3
207	AKT1	AKT \| CWS6 \| PKB \| PKB-ALPHA \| PRKBA \| RAC \| RAC-ALPHA	v-akt murine thymoma viral oncogene homolog 1	14q32.32
7187	TRAF3	CAP-1 \| CAP1 \| CD40bp \| CRAF1 \| IIAE5 \| LAP1	TNF receptor associated factor 3	14q32.32
3320	HSP90AA1	EL52 \| HEL-S-65p \| HSP86 \| HSP89A \| HSP90A \| HSP90N \| HSPC1 \| HSPCA \| HSPCAL1 \| HSPCAL4 \| HSPN \| Hsp89 \| Hsp90 \| LAP-2 \| LAP2	heat shock protein 90kDa alpha family class A member 1	14q32.33
8554	PIAS1	DDXBP1 \| GBP \| GU/RH-II \| ZMIZ3	protein inhibitor of activated STAT 1	15q
2252	FGF7	HBGF-7 \| KGF	fibroblast growth factor 7	15q21.2
5371	PML	MYL \| PP8675 \| RNF71 \| TRIM19	promyelocytic leukemia	15q22
5604	MAP2K1	CFC3 \| MAPKK1 \| MEK1 \| MKK1 \| PRKMK1	mitogen-activated protein kinase kinase 1	15q22.1-q22.33
23604	DAPK2	DRP-1 \| DRP1	death-associated protein kinase 2	15q22.31
9915	ARNT2	WEDAS \| bHLHe1	aryl hydrocarbon receptor nuclear translocator 2	15q24
3480	IGF1R	CD221 \| IGFIR \| IGFR \| JTK13	insulin like growth factor 1 receptor	15q26.3
5579	PRKCB	PKC-beta \| PKCB \| PRKCB1 \| PRKCB2	protein kinase C beta	16p11.2
5595	MAPK3	ERK-1 \| ERK1 \| ERT2 \| HS44KDAP \| HUMKER1A \| P44ERK1 \| P44MAPK \| PRKM3 \| p44-ERK1 \| p44-MAPK	mitogen-activated protein kinase 3	16p11.2
1387	CREBBP	CBP \| KAT3A \| RSTS	CREB binding protein	16p13.3
8312	AXIN1	AXIN \| PPP1R49	axin 1	16p13.3
4313	MMP2	CLG4 \| CLG4A \| MMP-2 \| MMP-II \| MONA \| TBE-1	matrix metallopeptidase 2	16q12.2
5336	PLCG2	APLAID \| FCAS3 \| PLC-IV \| PLC-gamma-2	phospholipase C gamma 2	16q24.1
23533	PIK3R5	F730038I15Rik \| FOAP-2 \| P101-PI3K \| p101	phosphoinositide-3-kinase regulatory subunit 5	17p13.1
7157	TP53	BCC7 \| LFS1 \| P53 \| TRP53	tumor protein p53	17p13.1
1856	DVL2	-	dishevelled segment polarity protein 2	17p13.1
1398	CRK	CRKII \| p38	v-crk avian sarcoma virus CT10 oncogene homolog	17p13.3
9618	TRAF4	CART1 \| MLN62 \| RNF83	TNF receptor associated factor 4	17q11-q12
4843	NOS2	HEP-NOS \| INOS \| NOS \| NOS2A	nitric oxide synthase 2	17q11.2
6776	STAT5A	MGF \| STAT5	signal transducer and activator of transcription 5A	17q11.2
2064	ERBB2	CD340 \| HER-2 \| HER-2/neu \| HER2 \| MLN 19 \| NEU \| NGL \| TKR1	erb-b2 receptor tyrosine kinase 2	17q12
5914	RARA	NR1B1 \| RAR	retinoic acid receptor alpha	17q21
7473	WNT3	INT4 \| TETAMS	wingless-type MMTV integration site family member 3	17q21
3728	JUP	ARVD12 \| CTNNG \| DP3 \| DPIII \| PDGB \| PKGB	junction plakoglobin	17q21
2535	FZD2	Fz2 \| fz-2 \| fzE2 \| hFz2	frizzled class receptor 2	17q21.31
6774	STAT3	ADMIO \| APRF \| HIES	signal transducer and activator of transcription 3 (acute-phase response factor)	17q21.31
7484	WNT9B	WNT14B \| WNT15	wingless-type MMTV integration site family member 9B	17q21.32
3675	ITGA3	CD49C \| FRP-2 \| GAP-B3 \| GAPB3 \| ILNEB \| MSK18 \| VCA-2 \| VL3A \| VLA3a	integrin subunit alpha 3	17q21.33
2885	GRB2	ASH \| EGFRBP-GRB2 \| Grb3-3 \| MST084 \| MSTP084 \| NCKAP2	growth factor receptor bound protein 2	17q24-q25
8313	AXIN2	AXIL \| ODCRCS	axin 2	17q24.1
5578	PRKCA	AAG6 \| PKC-alpha \| PKCA \| PRKACA	protein kinase C alpha	17q24.2
10928	RALBP1	RIP1 \| RLIP1 \| RLIP76	ralA binding protein 1	18p11.3
284217	LAMA1	LAMA \| PTBHS \| S-LAM-alpha	laminin subunit alpha 1	18p11.3
4087	SMAD2	JV18 \| JV18-1 \| MADH2 \| MADR2 \| hMAD-2 \| hSMAD2	SMAD family member 2	18q21.1
4089	SMAD4	DPC4 \| JIP \| MADH4 \| MYHRS	SMAD family member 4	18q21.1
9063	PIAS2	ARIP3 \| DIP \| MIZ \| MIZ1 \| PIASX \| PIASX-ALPHA \| PIASX-BETA \| SIZ2 \| ZMIZ4	protein inhibitor of activated STAT 2	18q21.1
1630	DCC	CRC18 \| CRCR1 \| IGDCC1 \| MRMV1 \| NTN1R1	DCC netrin 1 receptor	18q21.3
596	BCL2	Bcl-2 \| PPP1R50	B-cell CLL/lymphoma 2	18q21.3
5605	MAP2K2	CFC4 \| MAPKK2 \| MEK2 \| MKK2 \| PRKMK2	mitogen-activated protein kinase kinase 2	19p13.3
27006	FGF22	-	fibroblast growth factor 22	19p13.3
898	CCNE1	CCNE \| pCCNE1	cyclin E1	19q12
7040	TGFB1	CED \| DPD1 \| LAP \| TGFB \| TGFbeta	transforming growth factor beta 1	19q13.1
1050	CEBPA	C/EBP-alpha \| CEBP	CCAAT/enhancer binding protein alpha	19q13.1
208	AKT2	HIHGHH \| PKBB \| PKBBETA \| PRKBB \| RAC-BETA	v-akt murine thymoma viral oncogene homolog 2	19q13.1-q13.2
112398	EGLN2	EIT6 \| HIF-PH1 \| HIFPH1 \| HPH-1 \| HPH-3 \| PHD1	egl-9 family hypoxia-inducible factor 2	19q13.2
5296	PIK3R2	MPPH \| MPPH1 \| P85B \| p85 \| p85-BETA	phosphoinositide-3-kinase regulatory subunit 2	19q13.2-q13.4
2323	FLT3LG	FL \| FLT3L	fms related tyrosine kinase 3 ligand	19q13.3
581	BAX	BCL2L4	BCL2-associated X protein	19q13.3-q13.4
26291	FGF21	-	fibroblast growth factor 21	19q13.33
354	KLK3	APS \| KLK2A1 \| PSA \| hK3	kallikrein related peptidase 3	19q13.41
7482	WNT2B	WNT13	wingless-type MMTV integration site family member 2B	1p13
4893	NRAS	ALPS4 \| CMNS \| N-ras \| NCMS \| NRAS1 \| NS6	neuroblastoma RAS viral (v-ras) oncogene homolog	1p13.2
3716	JAK1	JAK1A \| JAK1B \| JTK3	Janus kinase 1	1p32.3-p31.3
3065	HDAC1	GON-10 \| HD1 \| RPD3 \| RPD3L1	histone deacetylase 1	1p34
8503	PIK3R3	p55 \| p55-GAMMA \| p55PIK	phosphoinositide-3-kinase regulatory subunit 3	1p34.1
8643	PTCH2	PTC2	patched 2	1p34.1
6513	SLC2A1	CSE \| DYT17 \| DYT18 \| DYT9 \| EIG12 \| GLUT \| GLUT-1 \| GLUT1 \| GLUT1DS \| HTLVR \| PED \| SDCHCN	solute carrier family 2 member 1	1p34.2
1441	CSF3R	CD114 \| GCSFR	colony stimulating factor 3 receptor	1p35-p34.3
1855	DVL1	DRS2 \| DVL \| DVL1L1 \| DVL1P1	dishevelled segment polarity protein 1	1p36
1870	E2F2	E2F-2	E2F transcription factor 2	1p36
998	CDC42	CDC42Hs \| G25K \| TKS	cell division cycle 42	1p36.1
5293	PIK3CD	APDS \| IMD14 \| P110DELTA \| PI3K \| p110D	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta	1p36.2
2475	MTOR	FRAP \| FRAP1 \| FRAP2 \| RAFT1 \| RAPT1 \| SKS	mechanistic target of rapamycin	1p36.2
842	CASP9	APAF-3 \| APAF3 \| ICE-LAP6 \| MCH6 \| PPP1R56	caspase 9	1p36.21
54361	WNT4	SERKAL \| WNT-4	wingless-type MMTV integration site family member 4	1p36.23-p35.1
10401	PIAS3	ZMIZ5	protein inhibitor of activated STAT 3	1q21
405	ARNT	HIF-1-beta \| HIF-1beta \| HIF1-beta \| HIF1B \| HIF1BETA \| TANGO \| bHLHe2	aryl hydrocarbon receptor nuclear translocator	1q21
4914	NTRK1	MTC \| TRK \| TRK1 \| TRKA \| Trk-A \| p140-TrkA	neurotrophic tyrosine kinase, receptor, type 1	1q21-q22
1163	CKS1B	CKS1 \| PNAS-16 \| PNAS-18 \| ckshs1	CDC28 protein kinase regulatory subunit 1B	1q21.2
7170	TPM3	CAPM1 \| CFTD \| HEL-189 \| HEL-S-82p \| NEM1 \| OK/SW-cl.5 \| TM-5 \| TM3 \| TM30 \| TM30nm \| TM5 \| TPMsk3 \| TRK \| hscp30	tropomyosin 3	1q21.2
6258	RXRG	NR2B3 \| RXRC	retinoid X receptor gamma	1q22-q23
7175	TPR	-	translocated promoter region, nuclear basket protein	1q25
5743	PTGS2	COX-2 \| COX2 \| GRIPGHS \| PGG/HS \| PGHS-2 \| PHS-2 \| hCox-2	prostaglandin-endoperoxide synthase 2	1q25.2-q25.3
7188	TRAF5	MGC:39780 \| RNF84	TNF receptor associated factor 5	1q32
83593	RASSF5	Maxp1 \| NORE1 \| NORE1A \| NORE1B \| RAPL \| RASSF3	Ras association domain family member 5	1q32.1
89780	WNT3A	-	wingless-type MMTV integration site family member 3A	1q42
2271	FH	FMRD \| HLRCC \| LRCC \| MCL \| MCUL1	fumarate hydratase	1q42.1
54583	EGLN1	C1orf12 \| ECYT3 \| HALAH \| HIF-PH2 \| HIFPH2 \| HPH-2 \| HPH2 \| PHD2 \| SM20 \| ZMYND6	egl-9 family hypoxia-inducible factor 1	1q42.1
10000	AKT3	MPPH \| MPPH2 \| PKB-GAMMA \| PKBG \| PRKBG \| RAC-PK-gamma \| RAC-gamma \| STK-2	v-akt murine thymoma viral oncogene homolog 3	1q44
6789	STK4	KRS2 \| MST1 \| TIIAC \| YSK3	serine/threonine kinase 4	20q11.2-q13.2
598	BCL2L1	BCL-XL/S \| BCL2L \| BCLX \| Bcl-X \| PPP1R52	BCL2 like 1	20q11.21
5335	PLCG1	NCKAP3 \| PLC-II \| PLC1 \| PLC148 \| PLCgamma1	phospholipase C gamma 1	20q12-q13.1
4318	MMP9	CLG4B \| GELB \| MANDP2 \| MMP-9	matrix metallopeptidase 9	20q13.12
3911	LAMA5	-	laminin subunit alpha 5	20q13.2-q13.3
861	RUNX1	AML1 \| AML1-EVI-1 \| AMLCR1 \| CBF2alpha \| CBFA2 \| EVI-1 \| PEBP2aB \| PEBP2alpha	runt related transcription factor 1	21q22.3
637	BID	FP497	BH3 interacting domain death agonist	22q11.1
1399	CRKL	-	v-crk avian sarcoma virus CT10 oncogene homolog-like	22q11.21
5594	MAPK1	ERK \| ERK-2 \| ERK2 \| ERT1 \| MAPK2 \| P42MAPK \| PRKM1 \| PRKM2 \| p38 \| p40 \| p41 \| p41mapk \| p42-MAPK	mitogen-activated protein kinase 1	22q11.21
613	BCR	ALL \| BCR1 \| CML \| D22S11 \| D22S662 \| PHL	breakpoint cluster region	22q11.23
7477	WNT7B	-	wingless-type MMTV integration site family member 7B	22q13
5155	PDGFB	IBGC5 \| PDGF-2 \| PDGF2 \| SIS \| SSV \| c-sis	platelet derived growth factor subunit B	22q13.1
5880	RAC2	EN-7 \| Gx \| HSPC022 \| p21-Rac2	ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)	22q13.1
2033	EP300	KAT3B \| RSTS2 \| p300	E1A binding protein p300	22q13.2
9978	RBX1	BA554C12.1 \| RNF75 \| ROC1	ring-box 1, E3 ubiquitin protein ligase	22q13.2
83439	TCF7L1	TCF-3 \| TCF3	transcription factor 7 like 1	2p11.2
1496	CTNNA2	CAP-R \| CAPR \| CT114 \| CTNR	catenin alpha 2	2p12-p11.1
7039	TGFA	TFGA	transforming growth factor alpha	2p13
2956	MSH6	GTBP \| GTMBP \| HNPCC5 \| HSAP \| p160	mutS homolog 6	2p16
2034	EPAS1	ECYT4 \| HIF2A \| HLF \| MOP2 \| PASD2 \| bHLHe73	endothelial PAS domain protein 1	2p21-p16
2736	GLI2	CJS \| HPE9 \| PHS2 \| THP1 \| THP2	GLI family zinc finger 2	2q14
5899	RALB	-	v-ral simian leukemia viral oncogene homolog B	2q14.2
3685	ITGAV	CD51 \| MSK8 \| VNRA \| VTNR	integrin subunit alpha V	2q31-q32
3655	ITGA6	CD49f \| ITGA6B \| VLA-6	integrin subunit alpha 6	2q31.1
6772	STAT1	CANDF7 \| IMD31A \| IMD31B \| IMD31C \| ISGF-3 \| STAT91	signal transducer and activator of transcription 1	2q32.2
841	CASP8	ALPS2B \| CAP4 \| Casp-8 \| FLICE \| MACH \| MCH5	caspase 8	2q33-q34
7855	FZD5	C2orf31 \| HFZ5	frizzled class receptor 5	2q33.3
2335	FN1	CIG \| ED-B \| FINC \| FN \| FNZ \| GFND \| GFND2 \| LETS \| MSF	fibronectin 1	2q34
1286	COL4A4	CA44	collagen type IV alpha 4	2q35-q37
4286	MITF	CMM8 \| MI \| WS2 \| WS2A \| bHLHe32	microphthalmia-associated transcription factor	3p13
3913	LAMB2	LAMS \| NPHS5	laminin subunit beta 2	3p21
1499	CTNNB1	CTNNB \| MRD19 \| armadillo	catenin beta 1	3p21
7474	WNT5A	hWNT5A	wingless-type MMTV integration site family member 5A	3p21-p14
387	RHOA	ARH12 \| ARHA \| RHO12 \| RHOH12	ras homolog family member A	3p21.3
4292	MLH1	COCA2 \| FCC2 \| HNPCC \| HNPCC2 \| hMLH1	mutL homolog 1	3p21.3
11186	RASSF1	123F2 \| NORE2A \| RASSF1A \| RDA32 \| REH3P21	Ras association domain family member 1	3p21.3
7048	TGFBR2	AAT3 \| FAA3 \| LDS1B \| LDS2 \| LDS2B \| MFS2 \| RIIC \| TAAD2 \| TGFR-2 \| TGFbeta-RII	transforming growth factor beta receptor II	3p22
5915	RARB	HAP \| MCOPS12 \| NR1B2 \| RRB2	retinoic acid receptor beta	3p24.2
5468	PPARG	CIMT1 \| GLM1 \| NR1C3 \| PPARG1 \| PPARG2 \| PPARgamma	peroxisome proliferator activated receptor gamma	3p25
5894	RAF1	CMD1NN \| CRAF \| NS5 \| Raf-1 \| c-Raf	Raf-1 proto-oncogene, serine/threonine kinase	3p25
7476	WNT7A	-	wingless-type MMTV integration site family member 7A	3p25
7428	VHL	HRCA1 \| RCA1 \| VHL1 \| pVHL	von Hippel-Lindau tumor suppressor	3p25.3
10342	TFG	HMSNP \| SPG57 \| TF6 \| TRKT3	TRK-fused gene	3q12.2
868	CBLB	Cbl-b \| Nbla00127 \| RNF56	Cbl proto-oncogene B, E3 ubiquitin protein ligase	3q13.11
2932	GSK3B	-	glycogen synthase kinase 3 beta	3q13.3
5291	PIK3CB	P110BETA \| PI3K \| PI3KBETA \| PIK3C1	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta	3q22.3
5337	PLD1	-	phospholipase D1	3q26
2122	MECOM	AML1-EVI-1 \| EVI1 \| MDS1 \| MDS1-EVI1 \| PRDM3 \| RUSAT2	MDS1 and EVI1 complex locus	3q26.2
5290	PIK3CA	CLOVE \| CWS5 \| MCAP \| MCM \| MCMTC \| PI3K \| p110-alpha	phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha	3q26.3
2257	FGF12	FGF12B \| FHF1	fibroblast growth factor 12	3q28
1487	CTBP1	BARS	C-terminal binding protein 1	4p16
2261	FGFR3	ACH \| CD333 \| CEK2 \| HSFGFR3EX \| JTK4	fibroblast growth factor receptor 3	4p16.3
5156	PDGFRA	CD140A \| GAS9 \| PDGFR-2 \| PDGFR2 \| RHEPDGFRA	platelet derived growth factor receptor alpha	4q12
3815	KIT	C-Kit \| CD117 \| PBT \| SCFR	KIT proto-oncogene receptor tyrosine kinase	4q12
2250	FGF5	HBGF-5 \| Smag-82 \| TCMGLY	fibroblast growth factor 5	4q21
5602	MAPK10	JNK3 \| JNK3A \| PRKM10 \| SAPK1b \| p493F12 \| p54bSAPK	mitogen-activated protein kinase 10	4q22.1-q23
4790	NFKB1	CVID12 \| EBP-1 \| KBF1 \| NF-kB1 \| NF-kappa-B \| NF-kappaB \| NFKB-p105 \| NFKB-p50 \| NFkappaB \| p105 \| p50	nuclear factor of kappa light polypeptide gene enhancer in B-cells 1	4q24
1950	EGF	HOMG4 \| URG	epidermal growth factor	4q25
51176	LEF1	LEF-1 \| TCF10 \| TCF1ALPHA \| TCF7L3	lymphoid enhancer binding factor 1	4q25
2247	FGF2	BFGF \| FGF-2 \| FGFB \| HBGF-2	fibroblast growth factor 2	4q26
64399	HHIP	HIP	hedgehog interacting protein	4q28-q32
836	CASP3	CPP32 \| CPP32B \| SCA-1	caspase 3	4q34
6502	SKP2	FBL1 \| FBXL1 \| FLB1 \| p45	S-phase kinase-associated protein 2, E3 ubiquitin protein ligase	5p13
3673	ITGA2	BR \| CD49B \| GPIa \| HPA-5 \| VLA-2 \| VLAA2	integrin subunit alpha 2	5q11.2
5295	PIK3R1	AGM7 \| GRB1 \| IMD36 \| p85 \| p85-ALPHA	phosphoinositide-3-kinase regulatory subunit 1	5q13.1
324	APC	BTPS2 \| DP2 \| DP2.5 \| DP3 \| GS \| PPP1R46	adenomatous polyposis coli	5q21-q22
2246	FGF1	AFGF \| ECGF \| ECGF-beta \| ECGFA \| ECGFB \| FGF-1 \| FGF-alpha \| FGFA \| GLIO703 \| HBGF-1 \| HBGF1	fibroblast growth factor 1	5q31
7478	WNT8A	WNT8D	wingless-type MMTV integration site family member 8A	5q31
6932	TCF7	TCF-1	transcription factor 7 (T-cell specific, HMG-box)	5q31.1
1495	CTNNA1	CAP102	catenin alpha 1	5q31.2
1436	CSF1R	C-FMS \| CD115 \| CSF-1R \| CSFR \| FIM2 \| FMS \| HDLS \| M-CSF-R	colony stimulating factor 1 receptor	5q32
5159	PDGFRB	CD140B \| IBGC4 \| IMF1 \| JTK12 \| KOGS \| PDGFR \| PDGFR-1 \| PDGFR1 \| PENTT	platelet derived growth factor receptor beta	5q33.1
8817	FGF18	FGF-18 \| ZFGF5	fibroblast growth factor 18	5q34
7422	VEGFA	MVCD1 \| VEGF \| VPF	vascular endothelial growth factor A	6p12
3326	HSP90AB1	D6S182 \| HSP84 \| HSP90B \| HSPC2 \| HSPCB	heat shock protein 90kDa alpha family class B member 1	6p12
5467	PPARD	FAAR \| NR1C2 \| NUC1 \| NUCI \| NUCII \| PPARB	peroxisome proliferator activated receptor delta	6p21.2
1026	CDKN1A	CAP20 \| CDKN1 \| CIP1 \| MDA-6 \| P21 \| SDI1 \| WAF1 \| p21CIP1	cyclin-dependent kinase inhibitor 1A	6p21.2
6257	RXRB	DAUDI6 \| H-2RIIBP \| NR2B2 \| RCoR-1	retinoid X receptor beta	6p21.3
1871	E2F3	E2F-3	E2F transcription factor 3	6p22
3910	LAMA4	CMD1JJ \| LAMA3 \| LAMA4*-1	laminin subunit alpha 4	6q21
3066	HDAC2	HD2 \| RPD3 \| YAF1	histone deacetylase 2	6q21
3908	LAMA2	LAMM	laminin subunit alpha 2	6q22-q23
1956	EGFR	ERBB \| ERBB1 \| HER1 \| NISBD2 \| PIG61 \| mENA	epidermal growth factor receptor	7p12
2737	GLI3	ACLS \| GCPS \| GLI3-190 \| GLI3FL \| PAP-A \| PAPA \| PAPA1 \| PAPB \| PHS \| PPDIV	GLI family zinc finger 3	7p13
5898	RALA	RAL	v-ral simian leukemia viral oncogene homolog A (ras related)	7p15-p13
3569	IL6	BSF-2 \| BSF2 \| CDF \| HGF \| HSF \| IFN-beta-2 \| IFNB2 \| IL-6	interleukin 6	7p21
5154	PDGFA	PDGF-A \| PDGF1	platelet derived growth factor subunit A	7p22
5879	RAC1	MIG5 \| Rac-1 \| TC-25 \| p21-Rac1	ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)	7p22
8326	FZD9	CD349 \| FZD3	frizzled class receptor 9	7q11.23
8321	FZD1	-	frizzled class receptor 1	7q21
1021	CDK6	MCPH12 \| PLSTIRE	cyclin-dependent kinase 6	7q21-q22
3082	HGF	DFNB39 \| F-TCF \| HGFB \| HPTA \| SF	hepatocyte growth factor	7q21.1
51384	WNT16	-	wingless-type MMTV integration site family member 16	7q31
7472	WNT2	INT1L1 \| IRP	wingless-type MMTV integration site family member 2	7q31.2
6608	SMO	FZD11 \| Gx \| SMOH	smoothened, frizzled class receptor	7q32.3
673	BRAF	B-RAF1 \| BRAF1 \| NS7 \| RAFB1	B-Raf proto-oncogene, serine/threonine kinase	7q34
6469	SHH	HHG1 \| HLP3 \| HPE3 \| MCOPCB5 \| SMMCI \| TPT \| TPTPS	sonic hedgehog	7q36
3551	IKBKB	IKK-beta \| IKK2 \| IKKB \| IMD15 \| NFKBIKB	inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta	8p11.2
2260	FGFR1	BFGFR \| CD331 \| CEK \| FGFBR \| FGFR-1 \| FLG \| FLT-2 \| FLT2 \| HBGFR \| HH2 \| HRTFDS \| KAL2 \| N-SAM \| OGD \| bFGF-R-1	fibroblast growth factor receptor 1	8p11.23-p11.22
8822	FGF17	FGF-13 \| FGF-17 \| HH20	fibroblast growth factor 17	8p21
7976	FZD3	Fz-3	frizzled class receptor 3	8p21
26281	FGF20	FGF-20 \| RHDA2	fibroblast growth factor 20	8p22
6921	TCEB1	SIII \| eloC	transcription elongation factor B subunit 1	8q21.11
862	RUNX1T1	AML1-MTG8 \| AML1T1 \| CBFA2T1 \| CDR \| ETO \| MTG8 \| ZMYND2	runt related transcription factor 1; translocated to, 1 (cyclin D related)	8q22
9134	CCNE2	CYCE2	cyclin E2	8q22.1
8323	FZD6	FZ-6 \| FZ6 \| HFZ6 \| NDNC10	frizzled class receptor 6	8q22.3-q23.1
4609	MYC	MRTL \| MYCC \| bHLHe39 \| c-Myc	v-myc avian myelocytomatosis viral oncogene homolog	8q24.21
5747	PTK2	FADK \| FAK \| FAK1 \| FRNK \| PPP1R71 \| p125FAK \| pp125FAK	protein tyrosine kinase 2	8q24.3
1029	CDKN2A	ARF \| CDK4I \| CDKN2 \| CMM2 \| INK4 \| INK4A \| MLM \| MTS-1 \| MTS1 \| P14 \| P14ARF \| P16 \| P16-INK4A \| P16INK4 \| P16INK4A \| P19 \| P19ARF \| TP16	cyclin-dependent kinase inhibitor 2A	9p21
1612	DAPK1	DAPK	death-associated protein kinase 1	9q21.33
7185	TRAF1	EBI6 \| MGC:10353	TNF receptor associated factor 1	9q33-q34
7186	TRAF2	MGC:45012 \| TRAP \| TRAP3	TNF receptor associated factor 2	9q34
25	ABL1	ABL \| JTK7 \| bcr/abl \| c-ABL \| c-ABL1 \| p150 \| v-abl	ABL proto-oncogene 1, non-receptor tyrosine kinase	9q34.1
10319	LAMC3	OCCM	laminin subunit gamma 3	9q34.12
5900	RALGDS	RGDS \| RGF \| RalGEF	ral guanine nucleotide dissociation stimulator	9q34.3
6256	RXRA	NR2B1	retinoid X receptor alpha	9q34.3
1438	CSF2RA	CD116 \| CDw116 \| CSF2R \| CSF2RAX \| CSF2RAY \| CSF2RX \| CSF2RY \| GM-CSF-R-alpha \| GMCSFR \| GMR \| SMDP4	colony stimulating factor 2 receptor alpha subunit	Xp22.32 and Yp11.3
367	AR	AIS \| AR8 \| DHTR \| HUMARA \| HYSP1 \| KD \| NR3C4 \| SBMA \| SMAX1 \| TFM	androgen receptor	Xq12
331	XIAP	API3 \| BIRC4 \| IAP-3 \| ILP1 \| MIHA \| XLP2 \| hIAP-3 \| hIAP3	X-linked inhibitor of apoptosis	Xq25
2258	FGF13	FGF-13 \| FGF2 \| FHF-2 \| FHF2	fibroblast growth factor 13	Xq26.3